- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06575569
Effect of HIIT on Cardiopulmonary Function After PCI in Patients With Coronary Heart Disease
Effect of High-intensity Intermittent Rehabilitation Training on Cardiopulmonary Function After PCI in Patients With Coronary Heart Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
As one of the most causes mortality all over the world, coronary heart disease (CHD) contributes to about 1.78 billion in Europe, 0.36 all deaths in the United States and over 110 million individuals worldwide each year, which has been a heavy burden on health expenditure. The treatment ways of CHD mainly include life way, drugs, and percutaneous coronary intervention (PCI). Even though, in past decades PCI technique has developed rapidly and today is a main treatment for patients with CHD. It was reported than healthcare costs will reach $177 billion by 2024 in the United States. In Europe, productivity losses were £13,953 per person per year because of CHD. Despite the traditional treatment, costs and mortality owing to CHD are still high, which highlights the need for research of the relationships between CHD and systems other than the cardiovascular system and comorbidities. The investigators need to search for new measures to improve traditional treatment ways of CHD. With the development of high-throughput sequencing technology, numbers of studies have showed that closely relationship between gut microbiota and cardiopulmonary function, blood glucose, lipid and cholesterol profiles and some inflammatory markers in patients with chronic disease. Regulation of intestinal flora may have preventive effect on disease. However, the study for relationship of CHD and gut microbiota is few reports. Health is a topic of common concern around the world. Increasing attention to the status of CHD and finding exercise prescriptions that effectively regulate the intestinal flora may lay the foundation for the prevention and treatment of chronic diseases such as CHD.
Some experiments have demonstrated that High-intensity interval training (HIIT) can change the diversity and metabolic capacity of gut microbiota. Therefore, it is necessary to conduct more studies to figure out whether exercise training could improve gut microbiota and bring benefit to human.
This study will explore whether 12 weeks of HIIT can effectively change the structure of human with CHD intestinal flora, so as to provide a theoretical basis for the human with CHD and exercise intervention in the treatment of intestinal flora related diseases.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Nanjing, China
- Department of Cardiology ,the First Affiliated Hospital of Nanjing Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- coronary angiography confirmed patients with coronary heart disease, which was at least one coronary vessel with a stenosis greater than 70%.
- Age is 18-70 years old, and the clinical sinus rhythm is stable.
- Left ventricular ejection fraction was> 40%.
- Informed consent and voluntary participation.
Exclusion Criteria:
- Patients with severe organic cardiac and lung diseases.
- Patients with hemiplegia and other physical action disorders.
- A history of mental illness.(4) Uncontrolled hypertension, and hemodynamic instability.
- Severe nephropathy and severe peripheral artery disease.
- Patients with bone and joint diseases who are not suitable for exercise.
- Uncontrolled endocrine system and other diseases.
- Antibiotics and anti-diarrheal medications have not been used for at least 3 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: high-intensity interval training (HIIT) group
intensive interval training under the care of specialists for 12 weeks, 30-40 minutes per week, including starting 5-minute warm-up and last 5-minute cooling-off period, during exercise including 4 intervals, 85-95% of maximum heart rate (HR) reserve for 4 minutes, followed by 50-70% of maximum HR reserve for 3 minutes, so cycling 4 times.
|
Patients had no adverse events after 2 weeks of adaptive exercise training and voluntarily continued participants, intensive interval training under the care of specialists for 12 weeks, 30-40 minutes per week, including starting 5-minute warm-up and last 5-minute cooling-off period, during exercise including 4 intervals, 85-95% of maximum heart rate (HR) reserve for 4 minutes, followed by 50-70% of maximum HR reserve for 3 minutes, so cycling 4 times.
Specific exercise logs will be issued for patients to record exercise conditions and related exercise data, encouraged to exercise regularly and health education materials pushed by cardiovascular nurses.
Other Names:
|
|
Active Comparator: Moderate-intensity continuous training (MCT) group
patients exercise prescription for 12 weeks, 30-40 minutes, including 5 minutes of warm-up and cooling-off period of the last 5 minutes, during exercise intensity is 70-75% maximum heart rate reserve.
The warm-up and cooling-off periods can be performed by stretching, flexibility exercises (i.
e., neck, shoulders, upper back, hips, and ankles), and medium to low intensity (50-70% heart rate reserve).
|
Using routine postoperative care and follow-up, establish WeChat group as contact for postoperative follow-up, no adverse events after 2 weeks of adaptive exercise training and voluntary participants, patients exercise prescription for 12 weeks, 30-40 minutes, including 5 minutes of warm-up and cooling-off period of the last 5 minutes, during exercise intensity is 70-75% maximum heart rate reserve.
The warm-up and cooling-off periods can be performed by stretching, flexibility exercises (i.
e., neck, shoulders, upper back, hips, and ankles), and medium to low intensity (50-70% heart rate reserve).
Specific exercise logs will be issued for patients to record exercise conditions and related exercise data, encouraged to exercise regularly and pushed health education materials by cardiovascular nurses.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Plasma metabolite Traumatic acid
Time Frame: 12 weeks
|
Plasma
|
12 weeks
|
|
6MWT
Time Frame: 12 weeks
|
6-minute walk test
|
12 weeks
|
|
VO2peak
Time Frame: 12 weeks
|
CPET
|
12 weeks
|
|
Gut microbiome
Time Frame: 12 weeks
|
Fecal DNA isolation was performed using the QIA amp Fast DNA Stool Mini Kit.
After DNA extraction, fecal DNA was used for library preparation, and whole-genome shotgun sequencing was performed on the Illumina NovaSeq-6000 plat- form.
From the raw metagenomic sequencing data, low-quality reads were discarded by the sequencing facility, and reads belonging to human contaminations were removed by mapping the data to the reference genomes using Bowtie2 (RRID:SCR _ 016368 ; v2.4.5).
After filtering, on average, 54.8 million (SD = 14.7 million) paired reads per sample were obtained for subsequent analysis.
|
12 weeks
|
Collaborators and Investigators
Investigators
- Study Director: Leilei Chen, The First Affiliated Hospital with Nanjing Medical University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HIIT-PCI
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Heart Disease
-
Shenyang Northern HospitalRecruitingCoronary Heart Disease (CHD)China
-
Peking University Third HospitalCompletedCoronary Microvascular Dysfunction | Obstructive Coronary Heart DiseaseChina
-
Chang Gung University of Science and TechnologyChang Gung Memorial Hospital; Chang Gung University; National Science and Technology...Enrolling by invitationCoronary Heart Disease (CHD) | Coronary Arterial Disease (CAD)Taiwan
-
Centro de estudios en Cardiologia IntervencionistaCompletedCoronary Heart Disease | Coronary RestenosisArgentina
-
Shiyan City Renmin HospitalCompletedCoronary Heart Disease (CHD)China
-
Henan Institute of Cardiovascular EpidemiologyWithdrawnStable Coronary Heart Disease
-
Astana Medical UniversityCompletedCHD - Coronary Heart DiseaseKazakhstan
-
Second Affiliated Hospital, School of Medicine,...RenJi HospitalUnknown
-
Xiyuan Hospital of China Academy of Chinese Medical...UnknownStable Coronary Heart DiseaseChina
-
Charite University, Berlin, GermanyCompletedStable Coronary Heart DiseaseGermany
Clinical Trials on high-intensity interval training
-
University of MichiganCompletedGlucose IntoleranceUnited States
-
Universidad SurcolombianaMaciste Macias; Gilberto AstaizaRecruiting
-
Kuopio Research Institute of Exercise MedicineKuopio University Hospital; University of Basel; University of Eastern Finland; Social Insurance Institution, FinlandTerminatedUnstable Angina Pectoris | Acute Myocardial Infarction | Recurrent Myocardial InfarctionFinland
-
Riphah International UniversityCompleted
-
Cairo UniversityKasr El Aini HospitalCompletedDiabetes Mellitus, Type 2Egypt
-
Universidad Santo TomasCompletedMetabolic DiseasesColombia
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Wu JiarunCompletedBurnout,Motivation,Stress,Mental ToughnessMalaysia
-
Cairo UniversityRecruiting